☰

Matthew R. Blankenship - Publications

Affiliations: 
Western Illinois University, Macomb, IL, United States 
Area:
Psychology
Tree Info Grants Similar researchers Related pubs Distance to... Nearest Nobel PubMed Report error

5/22 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2018 Allen MT, Handy JD, Blankenship MR, Servatius RJ. THE DISTRESSED (TYPE D) PERSONALITY FACTOR OF SOCIAL INHIBITION, BUT NOT NEGATIVE AFFECTIVITY, ENHANCES EYEBLINK CONDITIONING. Behavioural Brain Research. PMID 29486267 DOI: 10.1016/j.bbr.2018.02.035  0.352
2005 Blankenship MR, Huckfeldt R, Steinmetz JJ, Steinmetz JE. The effects of amygdala lesions on hippocampal activity and classical eyeblink conditioning in rats. Brain Research. 1035: 120-30. PMID 15722052 DOI: 10.1016/J.Brainres.2004.11.061  0.54
2000 Blankenship MR, Finn PR, Steinmetz JE. A characterization of approach and avoidance learning in high-alcohol-drinking (HAD) and low-alcohol-drinking (LAD) rats. Alcoholism, Clinical and Experimental Research. 24: 1778-84. PMID 11141036 DOI: 10.1111/J.1530-0277.2000.Tb01981.X  0.599
2000 Steinmetz JE, Blankenship MR, Green JT, Smith GB, Finn PR. Evaluation of behavioral disinhibition in P/NP and HAD1/LAD1 rats. Progress in Neuro-Psychopharmacology & Biological Psychiatry. 24: 1025-39. PMID 11041542 DOI: 10.1016/S0278-5846(00)00122-6  0.546
1998 Blankenship MR, Finn PR, Steinmetz JE. A characterization of approach and avoidance learning in alcohol-preferring and alcohol-nonpreferring rats. Alcoholism, Clinical and Experimental Research. 22: 1227-33. PMID 9756037 DOI: 10.1111/J.1530-0277.1998.Tb03903.X  0.643
Low-probability matches (unlikely to be authored by this person)
2010 Bardgett ME, Points M, Kleier J, Blankenship M, Griffith MS. The H3 antagonist, ciproxifan, alleviates the memory impairment but enhances the motor effects of MK-801 (dizocilpine) in rats. Neuropharmacology. 59: 492-502. PMID 20621107 DOI: 10.1016/j.neuropharm.2010.07.004  0.2
2009 Bardgett ME, Points M, Roflow J, Blankenship M, Griffith MS. Effects of the H(3) antagonist, thioperamide, on behavioral alterations induced by systemic MK-801 administration in rats. Psychopharmacology. 205: 589-97. PMID 19466392 DOI: 10.1007/s00213-009-1566-8  0.189
2008 Blankenship M. The unlawful internet gambling enforcement act: A bad gambling act? You betcha! Rutgers Law Review. 60: 485-518.  0.071
1989 Blankenship M, Wilhoit K, Blankenship C. Leadership: do it with style. Nursing Management. 20: 81-2. PMID 2922173  0.068
2012 Vieraitis LM, Piquero NL, Piquero AR, Tibbetts SG, Blankenship M. Do Women and Men Differ in Their Neutralizations of Corporate Crime? Criminal Justice Review. 37: 478-493. DOI: 10.1177/0734016812465745  0.061
2007 Durr JA, Blankenship M, Chauhan SS, Pennington MW. Targeted tyrosine iodination in a multi-tyrosine vasopressin analog. Journal of Peptide Science : An Official Publication of the European Peptide Society. 13: 756-61. PMID 17803258 DOI: 10.1002/Psc.890  0.051
2009 Pitt J, Roth W, Lacor P, Smith AB, Blankenship M, Velasco P, De Felice F, Breslin P, Klein WL. Alzheimer's-associated Abeta oligomers show altered structure, immunoreactivity and synaptotoxicity with low doses of oleocanthal. Toxicology and Applied Pharmacology. 240: 189-97. PMID 19631677 DOI: 10.1016/J.Taap.2009.07.018  0.044
2013 Piquero NL, Vieraitis LM, Piquero AR, Tibbetts SG, Blankenship M. The Interplay of Gender and Ethics in Corporate Offending Decision-Making Journal of Contemporary Criminal Justice. 29: 385-398. DOI: 10.1177/1043986213496379  0.041
1985 Harshman S, Burt AM, Robinson JP, Blankenship M, Harshman DL. Disruption of myelin sheaths in mouse brain in vitro and in vivo by staphylococcal alpha-toxin. Toxicon : Official Journal of the International Society On Toxinology. 23: 801-6. PMID 4089875  0.027
2012 Blankenship M. Spontaneous interventions [2] Architect. 101: 16.  0.022
2010 Kar K, Blankenship MR. Road safety audit: Findings from successful applications in Arizona Transportation Research Record. 113-120. DOI: 10.3141/2182-15  0.021
2009 Kar K, Blankenship MR. Road safety audits for pedestrian facilities Public Roads. 73.  0.016
1998 Vesely DL, Overton RM, Blankenship M, McCormick MT, Schocken DD. Atrial natriuretic peptide increases urodilatin in the circulation. American Journal of Nephrology. 18: 204-13. PMID 9627036  0.01
1996 Vesely DL, Blankenship M, Douglass MA, McCormick MT, Rodriguez-Paz G, Schocken DD. Atrial natriuretic peptide increases adrenomedullin in the circulation of healthy humans. Life Sciences. 59: 243-54. PMID 8699935  0.01
1979 Szmigielski S, Blankenship M, Robinson JP, Harshman S. Injury of myelin sheaths in isolated rabbit vagus nerves by alpha-toxin of Staphylococcus aureus. Toxicon : Official Journal of the International Society On Toxinology. 17: 363-71. PMID 494318  0.01
1970 Blankenship M, Memark C. Lichen planus and lichen nitidus. Archives of Dermatology. 101: 488. PMID 5440824  0.01
1963 BLANKENSHIP M. DERMATITIS DUE TO SHOES. Postgraduate Medicine. 34: 391-3. PMID 14052421  0.01
Hide low-probability matches.